How much funding has Chromatin Bioscience raised?

Chromatin Bioscience has raised $150K in total funding, most recently a Grant round.

Who are Chromatin Bioscience's investors?

Chromatin Bioscience's investors include Scottish Enterprise.

What industry is Chromatin Bioscience in?

Chromatin Bioscience operates in Biotech.

How many employees does Chromatin Bioscience have?

Chromatin Bioscience has 1-10 employees.

Chromatin Bioscience

Customised Gene Expression Systems

Biotech

Employees: 1–10
Business Model: B2B
Website: chromatinbio.com

Total Funding: $150K
Last Round: $150K Grant
Rounds: 1

About

Chromatin Bioscience designs synthetic gene regulatory elements — including promoters and expression cassettes — using bioinformatics to mine genomic datasets. Their technology enables cell-selective, controllable gene expression for cell and gene therapies, biologics manufacturing, industrial biotech, and agricultural biotech. The company partners with pharma firms including Astellas and Purespring Therapeutics.

Summary

Chromatin Bioscience is a Biotech company. It has raised $150K in total across 1 round. Investors include Scottish Enterprise.